Sign inJoin waitlistJoin the waitlist

Johannes Czernin

Chair, Nuclear Medicine and Theranostics · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · ·

History

Nuclear Medicine and Theranostics Department · UCLA David Geffen School of Medicine/UCLA Medical Center
Present
UCLA Nuclear Medicine Division · UCLA David Geffen School of Medicine/UCLA Medical Center
Present
Ahmanson Translational Imaging Division · UCLA David Geffen School of Medicine/UCLA Medical Center
Present

Nuclear Medicine
UCLA David Geffen School of Medicine/UCLA Medical Center
1992–1995
Medizinische Universität Wien
1979–1983

Research

A tabulated summary of the FDG PET literature
Review · Journal of Nuclear Medicine · 2001 · 677 citations
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
JAMA Oncology · 2019 · 672 citations
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome
JAMA · 2001 · 650 citations

Jeremie Calais
118 papers · 2 as a fellow
Martin Allen-Auerbach
63 papers · 1 as a resident
Heinrich Schelbert
45 papers
Daniel Silverman
42 papers · 1 as a fellow
WW
Wolfgang Weber
39 papers
MB
Matthias Benz
36 papers · 19 as a resident
Matthew Rettig
32 papers
Andrei Gafita
29 papers · 14 as a resident
Robert Reiter
29 papers
Thomas Hope
29 papers · 1 as a fellow
Amar Kishan
25 papers · 2 as a resident
CS
Christiaan Schiepers
25 papers

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $943.5K · University of California Los Angeles
1996–2030
Multidimensional Analyses to Improve PSMA-RPT Efficacy in mCRPC
National Cancer Institute · R01
Contact PI · $2.1M · University of California Los Angeles
2023–2028
PET Imaging-Guided Personalized Therapy in Pancreatic Cancer
National Cancer Institute · R01
PI · $2.8M · University of California Los Angeles
2014–2020
A New Theranostic System for PET Image Guided Radiotherapy of Cancer
National Cancer Institute · R21
Contact PI · $362.4K · University of California Los Angeles
2013–2017

Clinical trials

Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
Principal investigator · Recruiting · Phase 1
Jonsson Comprehensive Cancer Center
2024–2027
Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
2019
68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery
Principal investigator · Completed
Jonsson Comprehensive Cancer Center
2016–2021
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy
Principal investigator · Completed · Phase 3
Jonsson Comprehensive Cancer Center
2016–2021